Active Ingredient(s): Erythromycin + Sulfisoxazole
FDA Approved: * June 15, 1988
Pharm Company: * ALRA
Category: Ear Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Eryzole Overview

Erythromycin is an macrolide antibiotic useful for the treatment of a number of bacterial infections.[2] This includes respiratory tract infections, skin infections, chlamydia infections, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn.[2] Erythromycin may be used to improve delayed stomach emptying.[3] It can be given intravenously and by mouth.[2] An eye ointment is routinely recommended after delivery to prevent eye infections in...

Read more Eryzole Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Eryzole Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Erythromycin + Sulfisoxazole
  • Granule: 200mg/5ml + 600mg/5ml
  • Granule, for Reconstituti: 200mg/5ml + 600mg/5ml
  • Powder for Reconstitution: 200mg/5ml + 600mg/5ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (30 results)